微生物検査/臨床微生物学の世界市場予測(~2021)

◆英語タイトル:Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 2021
◆商品コード:MD-3092
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2016年6月3日
◆ページ数:202
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様利用)USD5,650 ⇒換算¥627,150見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥738,150見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥904,650見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、微生物検査/臨床微生物学の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、バリューチェーン分析、市場シェア分析、市場環境分析、用途別分析、製品別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global clinical microbiology market is projected to reach USD 5.77 Billion by 2021 from USD 3.35 Billion in 2016, growing at a CAGR of 11.5% from 2016 to 2021. Market growth can be attributed to factors such as technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world; and increasing funding, research grants, and public-private investments in the field of life science researches. However, reimbursement concerns and unfavorable regulatory scenario are restraining the growth of the market.
On the basis of products, the clinical microbiology market is segmented into instruments and reagents. The instruments segment is expected to account for the larger share of the global market in 2016. The dominant market position of the clinical microbiology instruments segment is mainly due to factors such as the high cost of instruments, significant adoption of conventional laboratory instruments among researchers & academia, technological advancements, and ongoing trend of laboratory automation among clinical laboratories. However, reagents segment is the faster-growing product category, growing at a double-digit CAGR during 2016 to 2021. Market growth of the reagents segment is propelled by factors such as growing trend of reagent rental agreements (along with instrument sales) by prominent reagent manufacturers, rising private-public funding for researches on specific infectious diseases, increasing market availability of pathogen-specific kits across the globe, and growing demand for specific clinical microbiology reagents during epidemic outbreaks.

On the basis of disease area, the global clinical microbiology market is segmented into respiratory diseases, bloodstream infections, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other diseases (cardiovascular disease, central nervous system infections, connective tissue & joint diseases, and skin diseases, among others). The respiratory diseases segment is expected to account for the largest share of the global market in 2016. This segment is also projected to grow fastest in the global market during 2016–2021. The significant growth potential offered by the respiratory disease segment can be attributed to factors such as the large patient population for respiratory diseases and rising prevalence of tuberculosis across developing countries.

Source: WHO, OECD, CIHR, FIPR, NLDAC, OPTN, IRODaT, GODT, GLOBOCAN, World Bank, Eurostat, ClinicalTrials.Gov, U.S. Census Bureau, U.S. Department of Health & Human Services, American Society of Nephrology, Canadian Society of Nephrology, European Journal of Cancer, Office of National Statistics (U.K.), MHLW, Ministry of Health (China), Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis

Geographically, the clinical microbiology market is classified into four regions— North America, Europe, Asia-Pacific, and the Rest of the World. North America and Europe are mature markets for clinical microbiology products. However, emerging regions such as Asia-Pacific (including Japan, China, and India, among others) are expected to become new revenue-generating pockets in the market in the next five years. The North American market is expected to hold the largest share of the global market in 2016. However, the Asia-Pacific market is projected to grow at the highest CAGR during the forecast period owing to the growing number of hospitals and clinical diagnostic laboratories in India and China; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and rising incidences of infectious diseases.

Product development and commercialization and was the key growth strategy adopted by prominent players to strengthen their global positioning in the clinical microbiology market. Moreover, strategies such as agreements, collaborations, and partnerships, acquisitions, and geographic expansions were also adopted by a significant number of market players to strengthen their product portfolios and expand their distribution networks in the global market during 2012–2015.

Leading players in the clinical microbiology market include bioMerieux S.A. (France), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.), among others.

【レポートの目次】

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency and Pricing
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Opportunity Indicators
2.2.1 Introduction
2.2.2 Demand-Side Analysis
2.2.2.1 Burden of Infectious Diseases
2.2.2.2 Healthcare Expenditure Patterns
2.2.2.3 Rapid Growth in Geriatric Population
2.2.2.4 Increasing Number of Clinical Researches in the Field of Clinical Microbiology
2.2.3 Supply-Side Analysis
2.2.3.1 Parent Market Analysis: Life Science Products Market
2.2.3.2 Number of New Product Launches: Clinical Microbiology Products
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Research Assumptions
2.5.1 Assumptions

3 Executive Summary (Page No. – 35)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 40)
4.1 Global Microbiology Testing Market (2016-2021)
4.2 Global Microbiology Testing Market, By Application (2016–2021)
4.3 Global Clinical Microbiology Market (2016-2021)
4.4 Global Clinical Microbiology Products Market, By Region (2016)
4.5 Global Clinical Microbiology Products Market, By Region (2016-2021)
4.6 Global Clinical Microbiology Market, By Disease Area (2016-2021)
4.7 Global Clinical Microbiology Market, By Country (2016–2021)

5 Market Overview (Page No. – 47)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Key Market Drivers
5.3.1.1 Technological Advancements
5.3.1.2 Rising Incidence of Infectious Diseases and Growing Outbreaks of Epidemics
5.3.1.3 Increased Funding, Research Grants, and Public-Private Investments
5.3.2 Key Market Restraints
5.3.2.1 Reimbursement Concerns
5.3.2.2 Unfavorable Regulatory Scenario
5.3.3 Key Market Opportunities
5.3.3.1 Growing Market Demand for Advanced Molecular Diagnostic Products
5.3.3.2 Improving Healthcare Infrastructure Across Emerging Countries
5.3.4 Key Market Challenges
5.3.4.1 Operational Barriers Related to Usage of Diagnostic Tests
5.3.4.2 Bundled Sales By Market Giants – A Key Challenge for Small and Emerging Reagent Manufacturers

6 Industry Insights (Page No. – 57)
6.1 Introduction
6.2 Value Chain Analysis
6.2.1 Clinical Microbiology Instruments
6.2.2 Clinical Microbiology Reagents and Kits
6.3 Industry Trends
6.3.1 Integration of Advanced Technologies With Molecular Diagnostic Processes
6.3.2 Ongoing Automation of Clinical Laboratory Techniques
6.4 Porter’s Five Forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat From Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry

7 Clinical Microbiology Market, By Product (Page No. – 62)
7.1 Introduction
7.2 Instruments
7.2.1 Laboratory Instruments
7.2.1.1 Incubators
7.2.1.2 Gram Stainers
7.2.1.3 Bacterial Colony Counters
7.2.1.4 Autoclave Sterilizers
7.2.1.5 Microbial Air Samplers
7.2.1.6 Anaerobic Culture Systems
7.2.1.7 Petri Dish Fillers
7.2.1.8 Blood Culture Systems
7.2.1.9 Microbial Culture Systems
7.2.1.10 Other Laboratory Instruments
7.2.2 Microbiology Analyzers
7.2.2.1 Molecular Diagnostic Instruments
7.2.2.2 Microscopes
7.2.2.3 Mass Spectrometers
7.3 Reagents
7.3.1 Pathogen-Specific Kits
7.3.2 General Reagents

8 Microbiology Testing Market, By Application (Page No. – 79)
8.1 Introduction
8.2 Pharmaceutical Applications
8.3 Clinical Applications
8.4 Food Testing Applications
8.5 Energy Applications
8.6 Chemical and Material Manufacturing Applications
8.7 Environmental Applications

9 Clinical Microbiology Market, By Disease Area (Page No. – 89)
9.1 Introduction
9.2 Respiratory Diseases
9.3 Bloodstream Infections
9.4 Gastrointestinal Diseases
9.5 Sexually Transmitted Diseases
9.6 Urinary Tract Infections (UTIS)
9.7 Periodontal Diseases
9.8 Other Diseases

10 Microbiology Testing/Clinical Microbiology Market, By Region (Page No. – 100)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe (RoE)
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific (RoAPAC)
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 125)
11.1 Overview
11.2 Market Share Analysis, By Key Player (2015)
11.3 Competitive Scenario
11.3.1 Product Approvals, Launches, and Enhancements
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Acquisitions
11.3.4 Expansions

12 Company Profiles (Page No. – 132)
12.1 Introduction
12.1.1 Geographic Benchmarking
12.2 Biomerieux S.A.
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Recent Developments
12.2.4 MnM View
12.3 Danaher Corporation
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Recent Developments
12.3.4 MnM View
12.4 Becton, Dickinson and Company
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Recent Developments
12.4.4 MnM View
12.5 Cepheid (U.S.)
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Recent Developments
12.5.4 MnM View
12.6 Abbott Laboratories, Inc.
12.6.1 Business Overview
12.6.2 Products Offered
12.6.3 Recent Developments
12.6.4 MnM View
12.7 Alere, Inc.
12.7.1 Business Overview
12.7.2 Products Offered
12.7.3 Recent Developments
12.8 Bio-Rad Laboratories Inc.
12.8.1 Business Overview
12.8.2 Bio-Rad Laboratories Inc.: Company Snapshot
12.8.3 Products Offered
12.8.4 Recent Developments
12.9 F. Hoffman-LA Roche Ltd.
12.9.1 Business Overview
12.9.2 Products Offered
12.9.3 Recent Developments
12.10 Bruker Corporation
12.10.1 Business Overview
12.10.2 Products Offered
12.10.3 Recent Developments
12.11 Hologic, Inc.
12.11.1 Business Overview
12.11.2 Products Offered
12.11.3 Recent Developments

13 Appendix (Page No. – 169)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables (74 Tables)

Table 1 Global Microbiology Testing Market Size, By Product, 2014-2021 (USD Million)
Table 2 Global Microbiology Testing Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 3 Microbiology Testing Instruments Market Size, By Region, 2014-2021 (USD Million)
Table 4 Global Microbiology Testing Laboratory Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 5 Microbiology Testing Laboratory Instruments Market Size, By Region, 2014-2021 (USD Million)
Table 6 Incubators Market Size, By Region, 2014-2021 (USD Million)
Table 7 Gram Stainers Market Size, By Region, 2014-2021 (USD Million)
Table 8 Bacterial Colony Counters Market Size, By Region, 2014-2021 (USD Million)
Table 9 Autoclave Sterilizers Market Size, By Region, 2014-2021 (USD Million)
Table 10 Microbial Air Samplers Market Size, By Region, 2014-2021 (USD Million)
Table 11 Anaerobic Culture Systems Market Size, By Region, 2014-2021 (USD Million)
Table 12 Petri Dish Fillers Market Size, By Region, 2014-2021 (USD Million)
Table 13 Blood Culture Systems Market Size, By Region, 2014-2021 (USD Million)
Table 14 Microbial Culture Systems Market Size, By Region, 2014-2021 (USD Million)
Table 15 Other Laboratory Instruments Market Size, By Region, 2014-2021 (USD Million)
Table 16 Global Microbiology Analyzers Market Size, By Type, 2014-2021 (USD Million)
Table 17 Microbiology Analyzers Market Size, By Region, 2014-2021 (USD Million)
Table 18 Molecular Diagnostic Instruments Market Size, By Region, 2014-2021 (USD Million)
Table 19 Microscopes Market Size, By Region, 2014-2021 (USD Million)
Table 20 Mass Spectrometers Market Size, By Region, 2014-2021 (USD Million)
Table 21 Global Microbiology Testing Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 22 Microbiology Testing Reagents Market Size, By Region, 2014-2021 (USD Million)
Table 23 Pathogen-Specific Kits Market Size, By Region, 2014-2021 (USD Million)
Table 24 General Reagents Market Size, By Region, 2014-2021 (USD Million)
Table 25 Global Microbiology Testing Market Size, By Application, 2014-2021 (USD Million)
Table 26 Microbiology Testing Market Size for Pharmaceutical Applications, By Region, 2014-2021 (USD Million)
Table 27 Microbiology Testing Market Size for Clinical Applications, By Region, 2014-2021 (USD Million)
Table 28 Microbiology Testing Market Size for Food Testing Applications, By Region, 2014-2021 (USD Million)
Table 29 Microbiology Testing Market Size for Energy Applications, By Region, 2014-2021 (USD Million)
Table 30 Microbiology Testing Market Size for Chemical and Material Manufacturing Applications, By Region, 2014-2021 (USD Million)
Table 31 Microbiology Testing Market Size for Environmental Applications, By Region, 2014-2021 (USD Million)
Table 32 Global Microbiology Testing Market Size, By Disease Area, 2014-2021 (USD Million)
Table 33 Microbiology Testing Market Size for Respiratory Diseases, By Region, 2014-2021 (USD Million)
Table 34 Microbiology Testing Market Size for Bloodstream Infections, By Region, 2014-2021 (USD Million)
Table 35 Microbiology Testing Market Size for Gastrointestinal Diseases, By Region, 2014-2021 (USD Million)
Table 36 Market Size for Sexually Transmitted Diseases, By Region, 2014-2021 (USD Million)
Table 37 Market Size for Urinary Tract Infections, By Region, 2014-2021 (USD Million)
Table 38 Market Size for Periodontal Diseases, By Region, 2014-2021 (USD Million)
Table 39 Market Size for Other Diseases, By Region, 2014-2021 (USD Million)
Table 40 Microbiology Testing Market Size, By Region, 2014–2021 (USD Million)
Table 41 Market Size, By Region, 2014–2021 (USD Million)
Table 42 North America: Microbiology Testing Market Size, By Application, 2014–2021 (USD Million)
Table 43 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 44 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 45 North America: Clinical Microbiology Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 46 North America: Market Size, By Disease Area, 2014–2021 (USD Million)
Table 47 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 48 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 49 Europe: Microbiology Testing Market Size, By Application, 2014–2021 (USD Million)
Table 50 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 51 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 52 Europe: Clinical Microbiology Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 53 Europe: Market Size, By Disease Area, 2014–2021 (USD Million)
Table 54 Germany: Clinical Microbiology Market Size, By Product, 2014–2021 (USD Million)
Table 55 U.K.: Clinical Microbiology Market Size, By Product, 2014–2021 (USD Million)
Table 56 France: Clinical Microbiology Market Size, By Product, 2014–2021 (USD Million)
Table 57 RoE: Clinical Microbiology Market Size, By Product, 2014–2021 (USD Million)
Table 58 Asia-Pacific: Microbiology Testing Market Size, By Application, 2014–2021 (USD Million)
Table 59 Asia-Pacific: Clinical Microbiology Market Size, By Country, 2014–2021 (USD Million)
Table 60 Asia-Pacific: Clinical Microbiology Market Size, By Product, 2014–2021 (USD Million)
Table 61 Asia-Pacific: Clinical Microbiology Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 62 Asia-Pacific: Clinical Microbiology Market Size, By Disease Area, 2014–2021 (USD Million)
Table 63 Japan: Clinical Microbiology Market Size, By Product, 2014–2021 (USD Million)
Table 64 China: Clinical Microbiology Market Size, By Product, 2014–2021 (USD Million)
Table 65 India: Clinical Microbiology Market Size, By Product, 2014–2021 (USD Million)
Table 66 RoAPAC: Clinical Microbiology Market Size, By Product, 2014–2021 (USD Million)
Table 67 RoW: Microbiology Testing Market Size, By Application, 2014–2021 (USD Million)
Table 68 RoW: Clinical Microbiology Market Size, By Product, 2014–2021 (USD Million)
Table 69 RoW: Clinical Microbiology Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 70 RoW: Clinical Microbiology Market Size, By Disease Area, 2014–2021 (USD Million)
Table 71 Top 5 Product Approvals, Launches, and Enhancements (2012–2016)
Table 72 Top 5 Agreements, Partnerships, and Collaborations (2012–2016)
Table 73 Top 5 Acquisitions (2012–2016)
Table 74 Top 5 Expansions, 2012–2016


List of Figures (62 Figures)

Figure 1 Research Design
Figure 2 China and India Had the Largest Tuberculosis Patient Population During 2005-2014
Figure 3 Global Prevalence of HIV Infections Among Adults (2014)
Figure 4 Healthcare Expenditure Across Major Countries: 2000–2013
Figure 5 Healthcare Expenditure Across Major Regions, 2000–2013
Figure 6 Increase in Geriatric Population, By Country (2011–2030)
Figure 7 Percentage Increase in Geriatric Population, By Region (1980–2010 vs 2010–2040)
Figure 8 Increase in the Proportion of the Elderly in the Overall Population, By Country (2011–2030)
Figure 9 Significant Public-Private Investments and Funding to Support Clinical Microbiology-Based Researches in Europe
Figure 10 Microbial Testing Expected to Be the Fastest-Growing Life Science Application Segment Till 2021
Figure 11 Number of New Product Launches: Clinical Microbiology Products, 2012–2015
Figure 12 Bottom-Up Approach: Clinical Microbiology Instruments Market
Figure 13 Bottom-Up Approach: Clinical Microbiology Reagents & Kits Market
Figure 14 Top-Down Approach: Microbiology Testing Market
Figure 15 Top-Down Approach: Clinical Microbiology Market
Figure 16 Data Triangulation
Figure 17 Assumptions of the Research Study
Figure 18 Global Microbiology Testing Market Size, By Application (2016 vs 2021)
Figure 19 Global Clinical Microbiology Products Market Size, By Region (2016)
Figure 20 Global Clinical Microbiology Market Size, By Disease Area (2016 vs 2021)
Figure 21 Clinical Microbiology Market Share, By Region (2016)
Figure 22 Market Growth Opportunities in the Microbiology Testing Industry
Figure 23 Pharmaceutical Applications to Dominate the Microbiology Testing Market Till 2021
Figure 24 Market Growth Opportunities in the Clinical Microbiology Industry
Figure 25 North America is Expected to Dominate Clinical Microbiology Market, By Product, in 2016
Figure 26 Laboratory Instruments to Dominate the Clinical Microbiology Products Market During the Forecast Period
Figure 27 Respiratory Diseases to Command the Largest Share of the Clinical Microbiology Market During the Study Period
Figure 28 China and India to Be the Fastest-Growing Markets for Clinical Microbiology Products Till 2021
Figure 29 Evolution of Diagnostic Techniques for Pathogen Identification (As of 2015)
Figure 30 Percentage Change in Annual Healthcare Expenditure—Developed vs Developing Countries (2005–2014)
Figure 31 Value Chain Analysis: Clinical Microbiology Instruments (2015)
Figure 32 Value Chain Analysis: Clinical Microbiology Reagents and Kits (2015)
Figure 33 Porter’s Five Forces Analysis: Clinical Microbiology Market (2015)
Figure 34 Clinical Microbiology Market Segmentation: By Product
Figure 35 Laboratory Instruments to Dominate the Clinical Microbiology Instruments Market Till 2021
Figure 36 Incubators to Dominate the Clinical Microbiology Laboratory Instruments Market During the Forecast Period
Figure 37 Molecular Diagnostic Instruments to Dominate the Clinical Microbiology Analyzers Market Till 2021
Figure 38 Pathogen-Specific Kits to Command the Largest Share of the Clinical Microbiology Reagents Market
Figure 39 Pharmaceutical Applications to Dominate the Global Microbiology Testing Market Till 2021
Figure 40 North America to Dominate the Global Microbiology Food Testing Applications Market Till 2021
Figure 41 North America to Dominate the Global Microbiology Environmental Applications Market Till 2021
Figure 42 Respiratory Diseases Segment to Dominate the Global Clinical Microbiology Market Till 2021
Figure 43 North America to Dominate the Global Clinical Microbiology Market for Stds Till 2021
Figure 44 North America to Dominate the Clinical Microbiology Market for Periodontal Diseases Till 2021
Figure 45 North America to Dominate the Clinical Microbiology Market By 2021
Figure 46 North America: : Clinical Microbiology Market Snapshot (2016-2021)
Figure 47 Europe: Clinical Microbiology Market Snapshot (2016-2021)
Figure 48 Asia-Pacific: Clinical Microbiology Market Snapshot (2016-2021)
Figure 49 Rest of the World: Clinical Microbiology Market Snapshot (2016-2021)
Figure 50 Product Development and Commercialization: A Key Growth Strategy Adopted By Majority of Market Players (2012-2016)
Figure 51 Global Clinical Microbiology Market Share, Key Player (2015)
Figure 52 Increasing Focus on Inorganic Strategies is Stimulating the Market Competition Among Key Product Manufacturers
Figure 53 Geographic Revenue Mix of the Top 5 Market Players (2015)
Figure 54 Biomerieux S.A.: Company Snapshot
Figure 55 Danaher Corporation: Company Snapshot
Figure 56 Becton, Dickinson and Company: Company Snapshot
Figure 57 Cepheid: Company Snapshot
Figure 58 Abbott Laboratories, Inc.: Company Snapshot
Figure 59 Alere, Inc.: Company Snapshot
Figure 60 F. Hoffman- LA Roche Ltd.: Company Snapshot
Figure 61 Bruker Corporation: Company Snapshot
Figure 62 Hologic, Inc.: Company Snapshot


【レポートのキーワード】

微生物検査、臨床微生物学、微生物検査機器、グラム染色、コロニー計数器、オートクレーブ滅菌装置、エアサンプラー、嫌気培養、分子診断装置、微生物検査試薬、キット、製薬、医療、食品検査、疾患、治療

★調査レポート[微生物検査/臨床微生物学の世界市場予測(~2021)]販売に関する免責事項
★調査レポート[微生物検査/臨床微生物学の世界市場予測(~2021)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆